No abstract

It has been widely documented that hemodialysis patients get a blocked secure response, that might result in a greater prevalence rate of viral diseases, according to Coronavirus epidemic 2019. . The point of this consider was to assess the recurrence of Covid -19 Immunoglobulin G (IgG) antibodies among hemodialysis patients. The current research included 90 hemodialysis patients (50 males and 40 female) who gone to Tikrit Teaching Hospital for the time from starting of December/2020 to the conclusion of May/2021. The Covid -19 -IgG was found in a higher rate in males than that in females (18.89% and 12.22% respectively). Also, non-significant relation was found between age and seropositivity for Covid -19 -IgG antibodies (p ≤ 0.05). Since patients receiving hemodialysis treatment are immunocompromised and can be at risk of infection of Covid -19.

No abstract

No abstract

No abstract